Computational Chemistry to Repurposing Drugs for the Control of COVID-19

  • Hassanzadeganroudsari M
  • Ahmadi A
  • Rashidi N
  • et al.
6Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Thus far, in 2021, 219 countries with over 175 million people have been infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a positive sense, single-stranded RNA virus, and is the causal agent for coronavirus disease (COVID-19). Due to the urgency of the situation, virtual screening as a computational modeling method offers a fast and effective modality of identifying drugs that may be effective against SARS-CoV-2. There has been an overwhelming abundance of molecular docking against SARS-CoV-2 in the last year. Due to the massive volume of computational studies, this systematic review has been created to evaluate and summarize the findings of existing studies. Herein, we report on computational articles of drugs which target, (1) viral protease, (2) Spike protein-ACE 2 interaction, (3) RNA-dependent RNA polymerase, and (4) other proteins and nonstructural proteins of SARS-CoV-2. Based on the studies presented, there are 55 identified natural or drug compounds with potential anti-viral activity. The next step is to show anti-viral activity in vitro and translation to determine effectiveness into human clinical trials.

Cite

CITATION STYLE

APA

Hassanzadeganroudsari, M., Ahmadi, A., Rashidi, N., Hossain, M., Habib, A., & Apostolopoulos, V. (2021). Computational Chemistry to Repurposing Drugs for the Control of COVID-19. Biologics, 1(2), 111–128. https://doi.org/10.3390/biologics1020007

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free